Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-06-17
1992-11-17
Schenkman, Leonard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514869, A61K 3144
Patent
active
051644010
ABSTRACT:
A method of treating a mammal in need of diruetic treatment by administering an effective diuretic amount of a diuretically active 3,7,9,9-tetrasubstituted 3,7-diazabicyclo[3,3,1]nonane compound, diuretic pharmaceutical compositions containing an effective diuretic amount of a diuretically active 3,7,9,9-tetrasubstituted 3,7-diazabicyclo[3,3,1]nonane compound; and previously unknown diuretically active 3,7,9,9-tetrasubstituted 3,7-diazabicyclo[3,3,1]nonane compounds containing an optionally substituted phenylalkyl group in the 3-position.
REFERENCES:
patent: 3962449 (1976-06-01), Binnig et al.
patent: 4183935 (1980-01-01), Binnig et al.
patent: 4550112 (1985-10-01), Schoen et al.
patent: 4906640 (1990-03-01), Schoen et al.
patent: 4912113 (1990-03-01), Schoen et al.
Burow Kurt
Buschmann Gerd
Farjam Arman
Kuehl Ulrich
Schoen Uwe
Kali-Chemie Pharma GmbH
Schenkman Leonard
LandOfFree
Method of diuretic treatment with 3,7-diazabicyclo[3,3,1]nonane does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of diuretic treatment with 3,7-diazabicyclo[3,3,1]nonane , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of diuretic treatment with 3,7-diazabicyclo[3,3,1]nonane will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1172353